# Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization

**Authors:** Irina Heid, Marija Trajkovic-Arsic, Fabian Lohöfer, Georgios Kaissis, Felix N. Harder, Moritz Mayer, Geoffrey J. Topping, Friderike Jungmann, Barbara Crone, Moritz Wildgruber, Uwe Karst, Lucia Liotta, Hana Algül, Hsi-Yu Yen, Katja Steiger, Wilko Weichert, Jens T. Siveke, Marcus R. Makowski, Rickmer F. Braren

PMC · DOI: 10.1007/s00259-025-07195-1 · European Journal of Nuclear Medicine and Molecular Imaging · 2025-03-18

## Full-text entities

- **Diseases:** PDAC (MESH:C537768)
- **Chemicals:** gemcitabine (MESH:D000093542)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316714/full.md

---
Source: https://tomesphere.com/paper/PMC12316714